KR910015571A - 소염성 벤즈옥사졸론 - Google Patents
소염성 벤즈옥사졸론 Download PDFInfo
- Publication number
- KR910015571A KR910015571A KR1019900002556A KR900002556A KR910015571A KR 910015571 A KR910015571 A KR 910015571A KR 1019900002556 A KR1019900002556 A KR 1019900002556A KR 900002556 A KR900002556 A KR 900002556A KR 910015571 A KR910015571 A KR 910015571A
- Authority
- KR
- South Korea
- Prior art keywords
- pharmaceutically acceptable
- addition salt
- acid addition
- acceptable acid
- group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/08—Bridged systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (10)
- 하기 일반식의 화합물 또는 그의 약학적으로 허용가능한 산 부가염 ;상기식에서, Alk는 Cn을 갖는 직쇄 또는 측쇄의 이가 알킬 그룹이고;n은 0,1,2,3,4또는 5이며; R1은 (C1-C3)알킬, (C1-C3)알콕시, (C1-C3)알킬티오, 수소, 할로, 페녹시, 페닐티오 또는 트리플루오로 메틸이고, R은 하기 (a)내지 (e)로 구성된 그룹중에서 선택된다;(여기에서, R2및 R3는 각각 독립적으로 수소, (C1-C4)알킬, (C1-C4)알콕시, (C1-C4)알킬티오, 또는 할로이고, X는 메틸렌(비치환되거나 하나의 메틸그룹으로 치환됨), 질소(비치환된 보호그룹으로 치환됨), 산소, 황, 설폭사이드, 또는 설폰이며, 2와 4위치사이의 점선은 2와 3위치사이 또는 3과 4위치사이의 임의의 결합을 나타낸);(여기에서, A및 B는 각각 독립적으로 산소 또는 황이다);(여기에서, R4및 R5는 각각 독립적으로, 수소 또는 (C1-C4)알킬이고, p는 0,1 또는 2이며, t는 0,1 또는 2이고 단 p와 t의 합은 1 또는 2이며, 물결선은 그 물결선을 함유하는 잔기가 엔도-또는 엑소-7-옥사바이시클로〔2,2,1〕헵탄-1-일 일수 있음을 나타낸다); (e)CH3-(CH2)m-Y-(여기에서, m은 1내지 3의 정수이고 Y는 산소, 황, 설폭사이드 또는 설폰이다).
- 제1항에 있어서, R이이고, n이 0 또는 1이며, R1이 5-할로이거나;또는 R이이고, n이 1이며, R이 5-(C1-C3)알킬 또는 (C1-C3)알콕시인 화합물 또는 그의 약학적으로 허용가능한 산 부가염.
- 제2항에 있어서, X가 산소이고, R1이 플루오로, 에틸 또는 메톡시인 화합물 또는 그의 약학적으로 허용가능한 산부가염.
- 제1항에 있어서, n이 1,2,3,4 또는 5이고, R1이 할로이며, R이 그룹(b)중에서 선택된 일원인 화합물 또는 그의 약학적으로 허용가능한 산부가염.
- 제1항에 있어서, n이 1이고, R1이 5-플루오로이며, R이 그룹(c)중에서 선택된 일원인 화합물 또는 그의 약학적으로 허용가능한 산부가염.
- 1항에 있어서, n이 1이고, R1이 5-플루오로이며, R이 그룹(d)중에서 선택된 일원인 화합물 또는 그의 약학적으로 허용가능한 산부가염.
- 1항에 있어서, n이 1,2,3,4 또는 5이고, R1이 5-할로이며, R이 그룹(e)중에서 선택된 일원인 화합물 또는 그의 약학적으로 허용가능한 산부가염.
- 제7항에 있어서, R1이 5-플루오로이고, m이 1이며, Y가 산소 또는 황인 화합물 또는 그의 약학적으로 허용가능한 산부가염.
- 효과량의 제1항의 화합물 또는 그의 약학적으로 허용가능한 산 부가염을 포유동물에 투여함을 포함하는, 리폭시게나제 또는 사이클로옥시게나제 효소의 억제를 필요로 하는 포유동물의 상기 효소를 억제하거나, 포유동물의 아라키돈산 대사산물이 매개한 질환상태를 예방 또는 치료하거나, 또는 포유동물의 알레르기 또는 염증 질환을 치료하기 위한 방법.
- 효과량의 제1항에 따른 화합물 또는 그의 약학적으로 허용가능한 산 부가염과 약학적으로 허용가능한 담체 또는 희석제를 포함하는 약학적 조성물.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4742989 | 1989-02-28 | ||
JP47429 | 1989-02-28 | ||
JP1-47429 | 1989-02-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR910015571A true KR910015571A (ko) | 1991-09-30 |
KR920010641B1 KR920010641B1 (ko) | 1992-12-12 |
Family
ID=12774907
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019900002556A KR920010641B1 (ko) | 1989-02-28 | 1990-02-27 | 소염성 벤즈옥사졸론 |
Country Status (24)
Country | Link |
---|---|
US (1) | US5086062A (ko) |
EP (1) | EP0385664B1 (ko) |
JP (1) | JPH0730053B2 (ko) |
KR (1) | KR920010641B1 (ko) |
CN (1) | CN1045264A (ko) |
AT (1) | ATE100091T1 (ko) |
AU (1) | AU617041B2 (ko) |
CA (1) | CA2010765A1 (ko) |
DD (1) | DD292256A5 (ko) |
DE (1) | DE69005852T2 (ko) |
DK (1) | DK0385664T3 (ko) |
ES (1) | ES2062332T3 (ko) |
FI (1) | FI900979A0 (ko) |
HU (1) | HUT58328A (ko) |
IE (1) | IE900695L (ko) |
IL (1) | IL93473A0 (ko) |
MY (1) | MY105263A (ko) |
NO (1) | NO900915L (ko) |
NZ (1) | NZ232707A (ko) |
PL (2) | PL163378B1 (ko) |
PT (1) | PT93257A (ko) |
RU (2) | RU2036913C1 (ko) |
YU (1) | YU37490A (ko) |
ZA (1) | ZA901480B (ko) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0678327B2 (ja) * | 1989-07-20 | 1994-10-05 | ファイザー製薬株式会社 | 4,5,6,7,―四置換ベンゾオキサゾロン類 |
JP2807577B2 (ja) * | 1990-06-15 | 1998-10-08 | エーザイ株式会社 | 環状アミド誘導体 |
DE10210779A1 (de) * | 2002-03-12 | 2003-10-09 | Merck Patent Gmbh | Cyclische Amide |
RU2477283C1 (ru) * | 2012-02-27 | 2013-03-10 | Федеральное государственное бюджетное учреждение науки Новосибирский институт органической химии им. Н.Н. Ворожцова Сибирского отделения Российской академии наук (НИОХ СО РАН) | 4,7-ДИМЕТИЛ-2-(2,4,5-ТРИМЕТОКСИФЕНИЛ)-3,4,4a,5,8,8a-ГЕКСАГИДРО-2H-4,8-ЭПОКСИХРОМЕН, ОБЛАДАЮЩИЙ АНАЛЬГЕЗИРУЮЩЕЙ АКТИВНОСТЬЮ |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3017977A1 (de) * | 1980-05-10 | 1981-11-19 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue substituierte 2(3h)-benzothiazolone |
FR2491066A1 (fr) * | 1980-09-29 | 1982-04-02 | Cerm Cent Europ Rech Mauvernay | Benzoxazolinones substituees en 6 par une chaine aminoalcool ou aminocetone, leur preparation et leur application en therapeutique |
GB8325370D0 (en) * | 1983-09-22 | 1983-10-26 | Fujisawa Pharmaceutical Co | Benzoxazoline and benzothiazoline derivatives |
US4835166A (en) * | 1986-06-09 | 1989-05-30 | Pfizer Inc. | Antiallergy and antiinflammatory agents |
DK288287A (da) * | 1986-06-09 | 1987-12-10 | Pfizer | Heterocycliske forbindelser samt farmaceutiske praeparater til behandling af allergiske eller inflammatoriske tilstande |
JPH0283376A (ja) * | 1988-09-19 | 1990-03-23 | Pfizer Pharmaceut Co Ltd | ベンゾオキサゾロン誘導体および抗アレルギー又は抗炎症組成物 |
-
1990
- 1990-02-21 IL IL93473A patent/IL93473A0/xx unknown
- 1990-02-23 DE DE90301941T patent/DE69005852T2/de not_active Expired - Fee Related
- 1990-02-23 PT PT93257A patent/PT93257A/pt not_active Application Discontinuation
- 1990-02-23 ES ES90301941T patent/ES2062332T3/es not_active Expired - Lifetime
- 1990-02-23 EP EP90301941A patent/EP0385664B1/en not_active Expired - Lifetime
- 1990-02-23 DK DK90301941.2T patent/DK0385664T3/da active
- 1990-02-23 AT AT90301941T patent/ATE100091T1/de not_active IP Right Cessation
- 1990-02-23 CA CA002010765A patent/CA2010765A1/en not_active Abandoned
- 1990-02-26 CN CN90101075A patent/CN1045264A/zh active Pending
- 1990-02-26 MY MYPI90000303A patent/MY105263A/en unknown
- 1990-02-27 NO NO90900915A patent/NO900915L/no unknown
- 1990-02-27 IE IE900695A patent/IE900695L/xx unknown
- 1990-02-27 ZA ZA901480A patent/ZA901480B/xx unknown
- 1990-02-27 JP JP2046077A patent/JPH0730053B2/ja not_active Expired - Lifetime
- 1990-02-27 HU HU901063A patent/HUT58328A/hu unknown
- 1990-02-27 FI FI900979A patent/FI900979A0/fi not_active Application Discontinuation
- 1990-02-27 RU SU904743392A patent/RU2036913C1/ru active
- 1990-02-27 PL PL90284026A patent/PL163378B1/pl unknown
- 1990-02-27 KR KR1019900002556A patent/KR920010641B1/ko not_active IP Right Cessation
- 1990-02-27 PL PL90288077A patent/PL163419B1/pl unknown
- 1990-02-27 DD DD90338191A patent/DD292256A5/de not_active IP Right Cessation
- 1990-02-27 NZ NZ232707A patent/NZ232707A/xx unknown
- 1990-02-27 YU YU00374/90A patent/YU37490A/xx unknown
- 1990-02-27 AU AU50566/90A patent/AU617041B2/en not_active Ceased
- 1990-05-29 US US07/529,971 patent/US5086062A/en not_active Expired - Lifetime
-
1991
- 1991-12-20 RU SU915010499A patent/RU2024512C1/ru active
Also Published As
Publication number | Publication date |
---|---|
NO900915L (no) | 1990-08-29 |
IE900695L (en) | 1990-08-28 |
NO900915D0 (no) | 1990-02-27 |
MY105263A (en) | 1994-09-30 |
PT93257A (pt) | 1990-08-31 |
US5086062A (en) | 1992-02-04 |
PL284026A1 (en) | 1991-04-08 |
IL93473A0 (en) | 1990-11-29 |
DK0385664T3 (da) | 1994-02-14 |
DE69005852T2 (de) | 1994-04-28 |
YU37490A (en) | 1992-05-28 |
ATE100091T1 (de) | 1994-01-15 |
PL163419B1 (pl) | 1994-03-31 |
DE69005852D1 (de) | 1994-02-24 |
CN1045264A (zh) | 1990-09-12 |
JPH0730053B2 (ja) | 1995-04-05 |
PL163378B1 (pl) | 1994-03-31 |
HUT58328A (en) | 1992-02-28 |
DD292256A5 (de) | 1991-07-25 |
CA2010765A1 (en) | 1990-08-31 |
ZA901480B (en) | 1991-10-30 |
PL288077A1 (en) | 1991-12-02 |
AU617041B2 (en) | 1991-11-14 |
AU5056690A (en) | 1990-09-06 |
NZ232707A (en) | 1991-01-29 |
RU2036913C1 (ru) | 1995-06-09 |
EP0385664A2 (en) | 1990-09-05 |
JPH03218368A (ja) | 1991-09-25 |
ES2062332T3 (es) | 1994-12-16 |
FI900979A0 (fi) | 1990-02-27 |
RU2024512C1 (ru) | 1994-12-15 |
EP0385664A3 (en) | 1991-03-06 |
EP0385664B1 (en) | 1994-01-12 |
KR920010641B1 (ko) | 1992-12-12 |
HU901063D0 (en) | 1990-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI955438A0 (fi) | N-asyylisulfamidihappoesterit (tai -tioesterit), N-asyylisulfonamidit ja N-sulfonyylikarbamiinihappoesterit (tai -tioesterit) hyperkolesteroleemisina aineina | |
BR8800503A (pt) | Composto isomeros(e),processo para a preparacao de um composto,composicao fungicida e processo para combater fungos | |
ATE177743T1 (de) | Langkettiger carbonsäureimidester | |
ID29452A (id) | 4-okso-1,4-dihidro-3-quinolinkarboksamida sebagai agen-agen antivirus | |
EP1052254A4 (en) | NITROGENIC HETEROCYCLIC DERIVATIVES AND DRUGS PRODUCED FROM SUCH DERIVATIVES | |
KR870000288A (ko) | (메트)-아크릴산 에스테르의 제조방법 | |
DE69705480D1 (de) | Verwendung von Oestrogenagonisten und -antagonisten zur Herstellung eines Medikaments zur Behandlung von Atherosklerose, unabhängig von Lipidsenkung | |
PT92824A (pt) | Processo para a preparacao de acrilatos e de composicaes fungicidas que os contem | |
KR940021059A (ko) | 지질 대사 개선제 | |
DE69615158D1 (de) | Phenylbenzoesäureester-derivate und flüssigkristallzubereitungen | |
PT732928E (pt) | Metodo para a reducao dos niveis de colesterol serico com 2,6-dialquil-4-sililfenois | |
KR900016098A (ko) | 카페인산의 유도체 및 이를 함유하는 약제학적 조성물 | |
DE60223904D1 (de) | Benzylaminanalogen | |
KR910015571A (ko) | 소염성 벤즈옥사졸론 | |
KR920018036A (ko) | 티아졸리디논 및 옥사졸리디논 유도체, 그의 제조방법 및 혈관확장제로서의 용도 | |
KR970707122A (ko) | 퀴놀린 유도체(quinoline derivative) | |
DE69415314D1 (de) | Neue bisoxadiazolidinderivate | |
KR890009867A (ko) | 비 펩타이드성 레닌 억제제 | |
CA2256247A1 (fr) | Nouveaux composes heterocycliques, leur procede de praparation et les compositions pharmaceutiques qui les contiennent | |
IS6115A (is) | Haló afleiður af 9-deoxó-9a-aza-9a-hómerýþrómýsíni A | |
KR940001901A (ko) | 지질 대사 개선 조성물 | |
DE69312849D1 (de) | Mercapto-acetamid-derivate | |
KR900009076A (ko) | 디하이드로피리딘 화합물을 함유하는 정맥 신전도 증진제 및 심장 비대 억제제 | |
KR950704335A (ko) | 포스폰산 디에스테르 유도체(phosphonic diester derivative) | |
KR890002190A (ko) | 퀴놀린 카르본산 유도체 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E902 | Notification of reason for refusal | ||
G160 | Decision to publish patent application | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
LAPS | Lapse due to unpaid annual fee |